News

Integra LifeSciences Welcomes Dr. Raymond Turner as CMO

Integra LifeSciences Welcomes Dr. Raymond Turner as CMO

Integra LifeSciences Welcomes New Leadership

Integra LifeSciences Holdings Corporation (Nasdaq:IART) is pleased to announce the appointment of Dr. Raymond Turner as the new corporate vice president and chief medical officer. This strategic decision marks a significant step forward in its commitment to enhancing patient outcomes.

Dr. Turner's Wealth of Experience

Bringing over 20 years of extensive experience in clinical operations, Dr. Turner has held various senior leadership positions in some of the most respected global MedTech companies. His new role at Integra will encompass overseeing worldwide medical affairs, clinical development activities, clinical research, trial operations, medical safety, and communications. Notably, he will continue his clinical practice, delivering neurosurgical care alongside his innovative leadership at Integra.

Vision for Patient Care

President and CEO Mojdeh Poul expressed, “Dr. Turner’s extensive medical background and clinical acumen will be vital as we enhance our focus on building robust clinical evidence.” His passion for advancing safety and quality in patient care is expected to introduce new, innovative solutions that can transform healthcare for patients worldwide.

Previous Roles and Achievements

Prior to his role at Integra, Dr. Turner served at Siemens Healthineers as the chief medical officer for its Endovascular Robotics division. His previous experience includes being a medical director for Cerenovus, a renowned company within the Johnson & Johnson MedTech umbrella. His impressive track record also includes his tenure at the Medical University of South Carolina, where he was a program director for the neurosurgery residency program and chief of the neuroscience department.

A Commitment to High Standards

Dr. Turner expressed his enthusiasm for joining Integra, stating, “I am excited to be joining Integra, an organization deeply committed to providing best-in-class, evidence-based products.” His leadership is expected to foster partnerships with healthcare professionals to further improve patient outcomes and maintain the highest standards of care.

Continued Clinical Involvement

Within his clinical roles, Dr. Turner has practiced surgery at PRISMA Health and most recently at Intermountain Health. He additionally holds a position as an examiner for the American Board of Neurological Surgery, showcasing his commitment to excellence within the field.

Educational Background

Dr. Turner earned his undergraduate degree in biology from Sacred Heart University in Connecticut before pursuing his medical degree at Karol Marcinkowski University of Medical Sciences in Poznan, Poland. His comprehensive training continued at the Cleveland Clinic, where he completed his residency in neurological surgery and a fellowship in endovascular neurosurgery. Dr. Turner has contributed significantly to the medical field, with over 150 peer-reviewed publications and involvement in more than 70 pre-clinical and clinical research studies.

About Integra LifeSciences

At Integra LifeSciences, our mission revolves around restoring patients' lives through innovative treatment pathways that advance patient outcomes. We are committed to setting new standards for surgical, neurological, and regenerative care, offering a broad portfolio of high-quality medical technology brands. To learn more about our products and the initiatives we are pursuing, please visit www.integralife.com.

Contact Information

Investor Relations:
Chris Ward
(609) 772-7736
chris.ward@integralife.com

Media:
Laurene Isip
(609) 208-8121
laurene.isip@integralife.com

Frequently Asked Questions

Who has been appointed as the new Chief Medical Officer at Integra LifeSciences?

Dr. Raymond Turner has been appointed as the new Chief Medical Officer at Integra LifeSciences.

What responsibilities will Dr. Turner have in his new role?

Dr. Turner will oversee worldwide medical affairs, clinical development activities, clinical research, and ensure medical safety and communications.

What is Dr. Turner's background prior to joining Integra?

He held leadership positions at Siemens Healthineers and Cerenovus, enhancing his expertise in MedTech.

What are Integra LifeSciences' primary objectives?

Integra is focused on restoring patients' lives, advancing treatment pathways, and maintaining high standards in medical care.

How can I learn more about Integra LifeSciences?

You can learn more about Integra and its products by visiting www.integralife.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 4

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
USFCR Wins 2026 Award for Federal Contracting Services

Updated Category News Views 7

Award-Winning Federal Contracting Strategies News from Clearwater, Florida: US Federal Contractor Registration (USFCR) just bagged the 2026 nod from Gov Business Review as the Federal Contracting Services of the Year. Now that's a feather in the cap worth talking about. This isn't some hallway compliment, folks. It's a signal that they've nailed how to get businesses...

Continue Reading
DCM Services Teams with AKUVO to Boost Estate Recoveries

Updated Category News Views 3

Revolutionizing Estate Recovery Practices Here's the scoop: DCM Services (DCMS), that big shot in estate account resolution, is hooking up with AKUVO to shake up how credit unions handle estate recoveries. This alliance is a clear nod to modernizing a process stuck in the past. Let’s face it, handling decedent and probate accounts is no cakewalk, and traditional methods...

Continue Reading
Modeling and Mental Health Join Forces for Wellness

Updated Category News Views 2

A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...

Continue Reading
Flex Dental Solutions Adds BNPL, Surcharging to FlexPayments

Updated Category News Views 7

Diving into Dental Finances: A New Moneymaker? It's about time someone shook up the dental payment scene, and Flex Dental Solutions seems to be the one doing it. They rolled out some intriguing new features for their FlexPayments platform aimed squarely at dental practices using Open Dental. What we're seeing here is their attempt to bridge a couple of financial headaches...

Continue Reading
CrossCountry Mortgage Boosts Loan Limits, Flexibility for 2027

Updated Category News Views 28

Trailblazing in the Mortgage Game Well, what do we have here? CrossCountry Mortgage, the big cheese of retail mortgage lenders, is cranking up their conforming loan limits to a hefty $845,000. They're jumping the gun on the Federal Housing Finance Agency's official 2027 announcement. It's a classic move—proactive, bold, and a bit of a gamble, if you ask me. They’re...

Continue Reading
Veteran Marketer Joins The Wisory's Advisory Board

Updated Category News Views 5

Tyrrell Schmidt Joins The Wisory's Board Out of the blue, The Wisory has snatched Tyrrell Schmidt right off the retirement bench. This doesn't seem like just another board seating; it smells like a calculated power play. Schmidt, fresh from her heavyweight stint as Global CMO at TD Bank, adds a spicy dose of marketing prowess to The Wisory's already loaded Advisory Board....

Continue Reading
Melissa Rivers Brings Her Wit Back to Emmys Carpet

Updated Category News Views 5

They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...

Continue Reading
Crystal Risotti: Leading IT Compliance in Healthcare

Updated Category News Views 6

A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...

Continue Reading
Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime

Updated Category News Views 4

Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...

Continue Reading

Top 5 Most Recently Viewed Articles

BioSig Technologies Updates on Merger and Share Issuance Plans

Updated Category News Views 169

BioSig Technologies Provides Merger Update LOS ANGELES and VANCOUVER, British Columbia — BioSig Technologies, Inc. (NASDAQ: BSGM), recently provided a significant update regarding its merger with Streamex Exchange Corporation. The recent developments aim to clarify the status of the merger and ensure all shareholders are informed. Details of the Merger Finalization The...

Continue Reading
Al Hurra Cuts Jobs and Merges Iraq Channel Amid Budget Cuts

Updated Category News Views 136

Al Hurra Faces Major Workforce Reductions The parent organization of the Arabic language broadcaster Al Hurra has announced significant layoffs, resulting in the elimination of 160 positions. This decision comes in the wake of a 20% budget cut mandated by the U.S. Congress, as revealed by the company’s CEO in a message to staff. Understanding the Budget Cuts Dr. Jeffrey...

Continue Reading
Strategies for Success in Hinge Research Institute's 2025 Study

Updated Category News Views 627

Innovative Strategies Highlighted in Hinge Research's 2025 Study Hinge Research Institute stands at the forefront of research on professional services growth. With its recent 10th Annual High Growth Study, the institute has delivered crucial insights into how successful firms thrive in today’s rapidly evolving market. The study not only illustrates the growth potential...

Continue Reading
Psyence Biomed Celebrates Milestones in Psilocybin Development

Updated Category News Views 125

Recent Developments in Psyence Biomed's Journey In a significant update shared by Psyence Biomedical Ltd. (Nasdaq: PBM), the company has showcased its achievements, reflecting a positive trajectory in the realm of psychedelic-based therapeutics. Highlights from the update included the impressive valuation of their stake in PsyLabs, strong clinical trial progress, and a...

Continue Reading
Rugby Resources Limited Expands Private Placement Offerings

Updated Category News Views 146

Rugby Resources Limited Expands Private Placement Opportunities Rugby Resources Ltd. (TSX-V: RUG) has announced an important development regarding its private placement offering. Responding to high subscriber demand, the company's board has authorized an increase in the number of available units, raising the offering from 60 million units to an impressive 81.84 million...

Continue Reading